Market cap
$4.1b
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
NPAT's 825% rise reflects a lower 46.4% tax rate, making the 228.6% PBT gain the more reliable read on operating performance.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$4.1b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
112.11x
Recent market cap compared with trailing earnings.
EPS
0.09
Recent filing-derived earnings per share.
PEG
0.14x
P/E compared with recent earnings growth.
EV/EBITDA
10.01x
Enterprise value compared with recent EBITDA.
P/FCF
11.27x
Market cap compared with recent free cash flow.
P/B
4.03x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
6.1%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY26 vs FY25
Revenue
$1b
Caveat: metric quality flags apply; use this value with basis context.
EBITDA
$726m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$37m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
$740m
+32.4% ↑ vs $559m
Full-year dividend per share
60.0c
+4.3% ↑ vs 57.5c
Operating profit
$287m
Caveat: metric quality flags apply; use this value with basis context.
Profit before tax
$69m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$199m
+145.7% ↑ vs $81m
Analysis ofCNU FY26Result releasedAnnolyse analysis published
What changed
The NPAT figure is flattered by the effective tax rate falling to 46.4% from 81.0%, so PBT growth is the cleaner signal of underlying operating momentum, and both tax rates remain well above a normalised charge.
Revenue rose 1.5% to $1b and EBITDA rose 3% to $726.0m from $705.0m. Operating cash flow increased 32.4% to $740.0m, and cash conversion improved to 101.9% of EBITDA from 79.3%. Capex fell 9.9% to $374.0m (36.3% of revenue, down from 40.9%), lifting free cash flow to $368.0m.
On the balance sheet, total assets rose 16.2% to $7.1b and equity nearly doubled to $1b from $567.0m, while gross borrowings rose 5.7% to $3.3b. Net debt to EBITDA held broadly steady at 4.29x versus 4.34x.
What matters
Cash generation looks genuinely stronger, not just accounting-driven: operating cash flow of $740.0m against EBITDA of $726.0m puts conversion at 101.9%, up from 79.3%, and a lower capex intensity (36.3% of revenue versus 40.9%) supports free cash flow of $368.0m. This matters because it gives more room to fund the dividend from cash generated in the period rather than from balance-sheet capacity.
The near-doubling of equity to $1b alongside a 16.2% rise in total assets is large enough to change the leverage picture, yet nothing in the disclosed commentary explains the driver. Net debt to EBITDA is effectively unchanged at 4.29x despite the equity move, so the practical effect on financial flexibility is limited so far, but the scale of the balance-sheet shift warrants explanation.
Expectations
Management's FY27 EBITDA guidance of $730 million to $760 million sits modestly above the FY26 outcome of $726.0m, implying continued but incremental EBITDA growth rather than a step-change.
The first-half to full-year shape shows NPAT more back-half weighted than revenue or EBITDA, with the interim period contributing 40.5% of full-year NPAT versus roughly 49% of revenue and EBITDA. This is consistent with normal seasonal skew rather than evidence of deteriorating trajectory, but there is no forward NPAT guidance to test it against.
Quality of result
The operating cash and free cash flow improvement look more durable, since operating cash flow rose in line with EBITDA growth and capex fell as a share of revenue, rather than the improvement coming from a one-off working-capital swing.
Return on equity improved to 3.6% from 0.7%, which is directionally positive but still low in absolute terms, and it is partly a function of the equity base nearly doubling, so the ratio should be read cautiously until the equity movement itself is explained.
Unresolved
This briefing cannot assess the specific driver of the equity and total-asset movement or the sustainability of the current effective tax rate, because the underlying explanation was not present in the supplied release excerpts.
Chat
Ask follow-up questions about Chorus's FY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
1. Chorus FY26 media release
FY26 / results announcement2. Chorus FY26 Investor Presentation
FY26 / results presentation3. Chorus FY26 Annual Report
FY26 / financial report1. Chorus FY25 media release
FY25 / results announcement2. Chorus FY25 Investor Presentation
FY25 / results presentation3. Chorus FY25 Annual Report
FY25 / financial report1. Media release - Chorus HY26 half year result
HY26 / media release2. Investor Presentation - Chorus HY26 half year result
HY26 / results presentation3. Management Commentary and Financial Statements - Chorus HY26 half year result
HY26 / financial report4. Results announcement - Chorus HY26 half year result
HY26 / results announcementRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 596.4pp, with a distortion flag in the result.
Leverage and balance-sheet risk
Net debt / EBITDA is 4.29x, -0.05x versus the prior comparable period.
Cash conversion quality
This result converted 101.9% of EBITDA to operating cash flow, +22.6pp versus the prior comparable period.
ROE and capital efficiency
ROE was 3.6%, +2.9pp versus the prior comparable period.
Get the next Chorus briefing and related NZX reporting-season updates by email.